BRPI0408827A - composições oftálmicas preservadas - Google Patents

composições oftálmicas preservadas

Info

Publication number
BRPI0408827A
BRPI0408827A BRPI0408827-1A BRPI0408827A BRPI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A BR PI0408827 A BRPI0408827 A BR PI0408827A
Authority
BR
Brazil
Prior art keywords
component
components
ophthalmic compositions
compositions
present
Prior art date
Application number
BRPI0408827-1A
Other languages
English (en)
Inventor
James N Chang
Richard Graham
Orest Olejnik
Stanley W Huth
Michelle Luu
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0408827A publication Critical patent/BRPI0408827A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSIçõES OFTáLMICAS PRESERVADAS". A presente invenção refere-se a composições oftálmicas que incluem um componente veículo, um componente de óxi-cloro, presente em uma quantidade efetiva para preservar a composição e pelo menos um componente adicional, por exemplo, um componente de borato e/ou um componente de glicerina, presente em uma quantidade efetiva para melhorar a eficácia de preservação da composição. As composições, preferencialmente, também incluem um ou mais outros componentes, tais como, componentes terapêuticos, por exemplo, componentes de quinoxalina e componentes polianiónicos, efetivos para prover as composições com uma ou mais funcionalidades.
BRPI0408827-1A 2003-03-27 2004-03-23 composições oftálmicas preservadas BRPI0408827A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/400,893 US20040191332A1 (en) 2003-03-27 2003-03-27 Preserved ophthalmic compositions
PCT/US2004/008913 WO2004087098A2 (en) 2003-03-27 2004-03-23 Preserved ophthalmic compositions

Publications (1)

Publication Number Publication Date
BRPI0408827A true BRPI0408827A (pt) 2006-04-04

Family

ID=32989309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408827-1A BRPI0408827A (pt) 2003-03-27 2004-03-23 composições oftálmicas preservadas

Country Status (9)

Country Link
US (1) US20040191332A1 (pt)
EP (1) EP1605912A2 (pt)
JP (1) JP2006521362A (pt)
CN (1) CN100528139C (pt)
AU (1) AU2004226466B2 (pt)
BR (1) BRPI0408827A (pt)
CA (1) CA2520521C (pt)
NZ (1) NZ542727A (pt)
WO (1) WO2004087098A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US8529927B2 (en) * 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
US7465412B2 (en) * 2004-10-28 2008-12-16 Ppg Industries Ohio, Inc. Calcium hypochlorite composition
US9452133B2 (en) * 2005-04-25 2016-09-27 KEM Patent Holdings, LLC Method for preventing nasolacrimal duct obstruction
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
KR101633449B1 (ko) * 2007-07-26 2016-06-24 아자드 파르마 아게 전기화학적으로 활성화된 치아염소산염 용액을 포함하는 약제학적 제제
US20090220618A1 (en) * 2008-02-29 2009-09-03 Erning Xia Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide
JP2013523828A (ja) 2010-04-07 2013-06-17 アラーガン インコーポレイテッド 眼科用組成物のための保存剤の組み合わせ
KR20130092957A (ko) 2010-04-07 2013-08-21 알러간, 인코포레이티드 안과용 처방용 보존제 조성물의 조합
US20140163080A1 (en) * 2011-02-03 2014-06-12 Gnt, Llc Compositions and Methods for Treatment of Glaucoma
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
WO2014074605A1 (en) * 2012-11-08 2014-05-15 Allergan, Inc. Preserved topical formulations with improved antimicrobial activity
US20140378401A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
TWI673071B (zh) * 2017-01-13 2019-10-01 National Taipei University Of Technology 眼科用組合物
US10293047B1 (en) * 2017-11-15 2019-05-21 Paragon BioTeck, Inc. Fluorescein and benoxinate compositions
TWI798498B (zh) * 2019-10-23 2023-04-11 永勝光學股份有限公司 具有高效抗微生物能力與潤滑效果的溶液

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US198209A (en) * 1877-12-18 Improvement in the manufacture of metallic leaf
US32201A (en) * 1861-04-30 John Neumann Faucet
US71874A (en) * 1867-12-10 haskell
US23098A (en) * 1859-03-01 Improvement in horse-rakes
US27811A (en) * 1860-04-10 Joseph kbech
US3278447A (en) * 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4411801A (en) * 1981-09-17 1983-10-25 Nl Industries, Inc. Low solids well servicing fluids
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4758595A (en) * 1984-12-11 1988-07-19 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
USRE32672E (en) * 1985-09-09 1988-05-24 Allergan, Inc. Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US5089509A (en) * 1988-09-15 1992-02-18 Allergan, Inc. Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US4861514A (en) * 1988-06-08 1989-08-29 The Drackett Company Compositions containing chlorine dioxide and their preparation
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5089053A (en) * 1989-11-09 1992-02-18 Polymer Technology Corporation Contact lens cleaning material and method
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0656779B1 (en) * 1992-08-28 2000-04-12 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
DE69333011T2 (de) * 1992-12-17 2004-03-25 Advanced Medical Optics, Inc., Santa Ana Oxidationsmittel und polyvinylpyrrolidon enthaltende desinfektionslösung für kontaktlinsen
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
WO1995010280A1 (en) * 1993-10-13 1995-04-20 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
JPH07316038A (ja) * 1994-05-23 1995-12-05 Ikeda Mohandou:Kk 粘膜投与用薬剤組成物
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6000534A (en) * 1996-08-16 1999-12-14 Allergan Sales, Inc. Contact lens disinfecting device and disinfection system
US6147081A (en) * 1996-09-26 2000-11-14 Rohto Pharmaceutical Co., Ltd. Ophthalmic solution
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
US5993864A (en) * 1997-07-11 1999-11-30 Kross; Robert D. Chlorine dioxide chelate compositions and method of use
CN1113650C (zh) * 1997-07-29 2003-07-09 法玛西雅厄普约翰美国公司 自体乳化剂形式的亲脂性化合物的药物组合物
DK0989851T3 (da) * 1997-07-29 2003-01-27 Upjohn Co Selvemulgerende formulering indeholdende sure lipofile forbindelser
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
JP4727816B2 (ja) * 1998-10-08 2011-07-20 エル． カラジョージアン、ハンパー 亜塩素酸塩と過酸化水素とを含有する共同作用抗菌性皮膚科・眼科製剤
DE69923987T2 (de) * 1998-10-08 2006-11-02 Karagoezian, Hampar L., San Juan Capistrano Synergistische antimikrobielle, dermatologische und ophtahalmologische zubereitung, die ein chlorit und wasserstoffperoxid enthalten
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
BR0109317A (pt) * 2000-07-14 2003-06-17 Allergan Inc Composições contendo componentes agonistas alfa-2-adrenérgicos
CA2416169C (en) * 2000-07-14 2008-09-23 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
US20040219219A1 (en) * 2000-07-14 2004-11-04 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20040214829A1 (en) * 2000-07-14 2004-10-28 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US7087190B2 (en) * 2003-03-20 2006-08-08 Ecolab Inc. Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

Also Published As

Publication number Publication date
CN100528139C (zh) 2009-08-19
AU2004226466B2 (en) 2009-01-22
EP1605912A2 (en) 2005-12-21
CA2520521A1 (en) 2004-10-14
CN1794973A (zh) 2006-06-28
US20040191332A1 (en) 2004-09-30
NZ542727A (en) 2008-09-26
AU2004226466A1 (en) 2004-10-14
WO2004087098A2 (en) 2004-10-14
WO2004087098A3 (en) 2005-06-02
JP2006521362A (ja) 2006-09-21
CA2520521C (en) 2013-05-14

Similar Documents

Publication Publication Date Title
BRPI0408827A (pt) composições oftálmicas preservadas
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0513491A (pt) composições inseticidas com base em inseticidas e saffeners selecionados
BRPI0516082A (pt) poligalactomananos catiÈnicos de alto ds para produtos de cuidado com a pele
BRPI0520014A2 (pt) emulsões oftálmicas estáveis de óleo-em-água com hialuronato de sódio para alìvio de olho seco
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
BRPI0608840B8 (pt) composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
BRPI0411016A (pt) composições antisépticas, processos e sistemas
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
BRPI0618918B8 (pt) uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
UY31718A1 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato y poliol
CO6220833A2 (es) Inmuno reguladores preparaciones y composiciones que incluyen los inmuno-reguladores pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
BRPI0519236A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogÊnicos, semente, e, uso dos compostos
BRPI0519230A2 (pt) misturas fungicidas, agente, processo para combater fungos nocivos fitopatogÊnicos, semente, e, uso dos compostos
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
BRPI0407529A (pt) uso de r-10-hidróxi-10,11-dihidro-carbamazepina em dor neuropática
BRPI0309768B8 (pt) composição lubrificante substancialmente anidra
BRPI0509784A (pt) misturas fungicidas para combater fungos nocivos fitopatogênicos, agente, processo para combater fungos nocivos fitopatogênicos, semente, e, uso dos compostos
BRPI0417170A (pt) composições, solução e métodos para uso e produção destas
BRPI0506840A (pt) misturas fungicidas combater fungos nocivos, agente, processo para combater fungos nocivos, semente, e uso dos compostos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/498, 33/14, 9/00; A61P 27/00

Ipc: A61K 31/498 (2011.01), A61K 33/14 (2011.01), A61K

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 22 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.